BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35096251)

  • 1. Utility and Limitations of Transient Elastography to Monitor Hepatic Steatosis, Hepatic Fibrosis, and Methotrexate-Associated Hepatic Disease in Psoriasis: A Systematic Review.
    Marsh RL; Kelly S; Mumtaz K; Kaffenberger J
    J Clin Aesthet Dermatol; 2021 Dec; 14(12):24-28. PubMed ID: 35096251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of transient elastography and FibroTest for monitoring hepatotoxicity in patients receiving methotrexate for psoriasis.
    Lynch M; Higgins E; McCormick PA; Kirby B; Nolan N; Rogers S; Lally A; Vellinga A; Omar H; Collins P
    JAMA Dermatol; 2014 Aug; 150(8):856-62. PubMed ID: 24964792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound liver elastography for the detection of liver fibrosis in patients with psoriasis and reactive arthritis on long-term methotrexate therapy: A cross-sectional study.
    Khandpur S; Yadav D; Jangid B; Kumar A; Shalimar ; Devasenathipathy K; Sharma R; Gupta SD; Kumar R; Kalaivani M
    Indian J Dermatol Venereol Leprol; 2020; 86(5):508-514. PubMed ID: 32525101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Transient Elastography in Detection of Liver Fibrosis in Psoriasis Patients - A Cross- Sectional Study.
    Neema S; Banerjee D; Radhakrishnan S; Vasudevan B; Sinha P; Oberoi B
    Indian Dermatol Online J; 2020; 11(3):387-390. PubMed ID: 32695699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring methotrexate-induced liver fibrosis in patients with psoriasis: utility of transient elastography.
    Cheng HS; Rademaker M
    Psoriasis (Auckl); 2018; 8():21-29. PubMed ID: 29785393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of transient elastography for detection of methotrexate-induced liver injury using Roenigk classification in Asian patients with psoriasis: a retrospective study.
    Rongngern P; Chularojanamontri L; Wongpraparut C; Silpa-Archa N; Chotiyaputta W; Pongpaibul A; Charatcharoenwitthaya P
    Arch Dermatol Res; 2017 Jul; 309(5):403-408. PubMed ID: 28303329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity.
    Montaudié H; Sbidian E; Paul C; Maza A; Gallini A; Aractingi S; Aubin F; Bachelez H; Cribier B; Joly P; Jullien D; Le Maître M; Misery L; Richard MA; Ortonne JP
    J Eur Acad Dermatol Venereol; 2011 May; 25 Suppl 2():12-8. PubMed ID: 21388454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
    Lertnawapan R; Chonprasertsuk S; Siramolpiwat S
    Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of magnetic resonance elastography and transient elastography in the diagnosis of hepatic fibrosis: a systematic review and meta-analysis.
    Bi J; Liu L; Qin T
    Ann Palliat Med; 2021 Aug; 10(8):8692-8700. PubMed ID: 34488358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated.
    Atallah E; Grove JI; Crooks C; Burden-Teh E; Abhishek A; Moreea S; Jordan KM; Ala A; Hutchinson D; Aspinall RJ; Murphy R; Aithal GP
    J Hepatol; 2023 May; 78(5):989-997. PubMed ID: 36702175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic steatosis as measured by the computed attenuation parameter predicts fibrosis in long-term methotrexate use.
    Tomaszewski M; Dahiya M; Mohajerani SA; Punja H; Ko HH; Sun M; Ramji A
    Can Liver J; 2021; 4(4):370-380. PubMed ID: 35989896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome and female gender, but not methotrexate, are the important associations of significant liver fibrosis in patients with moderate-to-severe psoriasis as detected by transient elastography.
    Mahajan R; Dogra S; Handa S; Razmi TM; Narang T; Rathi S; Dhiman RK; Saikia B; Karim A
    Indian J Dermatol Venereol Leprol; 2020; 86(6):649-655. PubMed ID: 32643632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and Risk Factors of Hepatic Fibrosis in Psoriatic Patients Receiving Methotrexate with Concomitant Acitretin Therapy and Methotrexate Monotherapy.
    Rattanakaemakorn P; Pinyowiwat P; Iamsumang W; Chanprapaph K; Suchonwanit P
    Drug Des Devel Ther; 2021; 15():2299-2307. PubMed ID: 34093007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update of liver fibrosis and steatosis with transient elastography (Fibroscan).
    Wong GL
    Gastroenterol Rep (Oxf); 2013 Jul; 1(1):19-26. PubMed ID: 24759663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance elastography and transient elastography as non-invasive analyses for liver fibrosis: can they obviate the need for liver biopsy in psoriasis patients treated with methotrexate?
    Kaffenberger BH; Kaffenberger JA; Wong H; Jarjour W; Levin D; Bechtel MA
    Int J Dermatol; 2015 Jul; 54(7):752-6. PubMed ID: 26108262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
    Imajo K; Kessoku T; Honda Y; Tomeno W; Ogawa Y; Mawatari H; Fujita K; Yoneda M; Taguri M; Hyogo H; Sumida Y; Ono M; Eguchi Y; Inoue T; Yamanaka T; Wada K; Saito S; Nakajima A
    Gastroenterology; 2016 Mar; 150(3):626-637.e7. PubMed ID: 26677985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient Elastography and Controlled Attenuation Parameter for Diagnosing Liver Fibrosis and Steatosis in Ontario: An Economic Analysis.
    Thavorn K; Coyle D
    Ont Health Technol Assess Ser; 2015; 15(19):1-58. PubMed ID: 26664666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
    Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
    Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound Shear Wave Elastography for Liver Disease. A Critical Appraisal of the Many Actors on the Stage.
    Piscaglia F; Salvatore V; Mulazzani L; Cantisani V; Schiavone C
    Ultraschall Med; 2016 Feb; 37(1):1-5. PubMed ID: 26871407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
    Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.